Ea. Kemppainen et al., RAPID MEASUREMENT OF URINARY TRYPSINOGEN-2 AS A SCREENING-TEST FOR ACUTE-PANCREATITIS, The New England journal of medicine, 336(25), 1997, pp. 1788-1793
Background Acute pancreatitis can be difficult to diagnose. We develop
ed a rapid dipstick screening test for pancreatitis, based on the immu
nochromatographic measurement of urinary trypsinogen-2. Methods We pro
spectively compared the urinary trypsinogen-2 dipstick test with a qua
ntitative urinary trypsinogen-2 assay, a urinary dipstick test for amy
lase, and serum and urinary amylase assays in 500 consecutive patients
with acute abdominal pain at two emergency departments. Acute pancrea
titis was diagnosed according to standardized criteria. Results The ur
inary trypsinogen-2 dipstick test was positive in 50 of the 53 patient
s with acute pancreatitis (sensitivity, 94 percent), including all 7 w
ith severe pancreatitis. Two patients with urinary trypsinogen-2 conce
ntrations below the sensitivity threshold of the test (50 ng per milli
liter) and one with a very high concentration had false negative resul
ts. The test was also positive in 21 of the 447 patients without pancr
eatitis (specificity, 95 percent), including 7 with abdominal cancers,
3 with cholangitis, and 2 with chronic pancreatitis. The sensitivity
and specificity of the dipstick test were similar to those of the quan
titative urinary trypsinogen-2 assay and higher than those of the urin
ary amylase dipstick test. The serum amylase assay had a sensitivity o
f 85 percent (with a cutoff value of 300 U per liter for the upper ref
erence limit) and a specificity of 91 percent. The sensitivity and spe
cificity of the urinary amylase assay (cutoff value, 2000 U per liter)
were 83 and 88 percent, respectively. Conclusions In patients with ac
ute abdominal pain seen in the emergency department, a negative dipsti
ck test for urinary trypsinogen-2 rules out acute pancreatitis with a
high degree of probability. A positive test usually identifies patient
s in need of further evaluation. (C)1997, Massachusetts Medical Societ
y.